Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › THC
GLENVIEW CAPITAL MANAGEMENT, LLC position in THC
TENET HEALTHCARE CORP · Health Care
GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 2,235,666 shares of THC (TENET HEALTHCARE CORP) in its Q2 2026 13F filing — a position valued at US$418.2M, representing 8.00% of its reported portfolio and ranking #3 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLENVIEW CAPITAL MANAGEMENT, LLC's THC position evolved
GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in THC in Q3 2023 at 6,865,142 shares (US$452.3M). The position peaked in Q1 2024 at 6,327,203 shares, worth US$665.1M. Across 12 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,235,666 shares valued at US$418.2M — an increase of 710,812 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2024 (shares rose 25% over the following quarter), a 43% trim in Q3 2024 (shares fell 24% over the following quarter), a 47% increase in Q2 2026 (shares rose 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.87M | $452.34M | New |
| Q4 2023 | 7.74M | $585.09M | Add |
| Q1 2024 | 6.33M | $665.05M | Reduce |
| Q2 2024 | 4.67M | $620.68M | Reduce |
| Q3 2024 | 2.66M | $441.89M | Reduce |
| Q4 2024 | 2.84M | $358.13M | Add |
| Q1 2025 | 3.39M | $456.61M | Add |
| Q2 2025 | 2.93M | $515.68M | Reduce |
| Q3 2025 | 2.32M | $471.80M | Reduce |
| Q4 2025 | 1.98M | $394.21M | Reduce |
| Q1 2026 | 1.52M | $287.76M | Reduce |
| Q2 2026 | 2.24M | $418.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 39 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), MANNING & NAPIER ADVISORS LLC (US$168.8M), EMINENCE CAPITAL, LP (US$149.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.43M sh · $829.06M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 901.64K sh · $168.76M · Q2 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on GLENVIEW CAPITAL MANAGEMENT, LLC
FAQ
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held THC?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in THC?
As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 2.24M shares of THC (TENET HEALTHCARE CORP), valued at $418.25M, representing 8.00% of its reported portfolio and ranking #3.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling THC?
In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC increased its position in THC. The position peaked in Q1 2024 at 6.33M shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, MANNING & NAPIER ADVISORS LLC, EMINENCE CAPITAL, LP, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.